Russell Investments Group, Ltd. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 52 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$7,977
+31.5%
37,9000.0%0.00%
Q1 2023$6,064
-71.2%
37,9000.0%0.00%
Q4 2022$21,034
-53.3%
37,9000.0%0.00%
Q3 2022$45,000
+95.7%
37,9000.0%0.00%
Q2 2022$23,000
-46.5%
37,9000.0%0.00%
Q1 2022$43,000
-49.4%
37,9000.0%0.00%
Q4 2021$85,000
-34.1%
37,9000.0%0.00%
Q3 2021$129,000
+14.2%
37,9000.0%0.00%
Q2 2021$113,000
-49.3%
37,900
-45.5%
0.00%
Q1 2021$223,000
+182.3%
69,535
+82.6%
0.00%
Q4 2020$79,000
+58.0%
38,078
-12.3%
0.00%
Q3 2020$50,000
+28.2%
43,409
-0.1%
0.00%
Q2 2020$39,000
+85.7%
43,451
+64.6%
0.00%
Q1 2020$21,000
-19.2%
26,400
-6.4%
0.00%
Q4 2019$26,000
-10.3%
28,200
-0.4%
0.00%
Q3 2019$29,000
-45.3%
28,300
-3.4%
0.00%
Q2 2019$53,000
+23.3%
29,300
+27.9%
0.00%
Q1 2019$43,000
+104.8%
22,900
+33.1%
0.00%
Q4 2018$21,000
-64.4%
17,200
-38.6%
0.00%
Q1 2018$59,000
-35.2%
28,000
-31.5%
0.00%
Q4 2017$91,000
+59.6%
40,900
-4.2%
0.00%
Q3 2017$57,000
-63.2%
42,700
-56.9%
0.00%
Q2 2017$155,000
-77.0%
99,100
-52.4%
0.00%
-100.0%
Q1 2017$673,000
+1040.7%
208,238
+394.6%
0.00%
Q4 2016$59,00042,1000.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders